Back to CVE records
Medium 6.3Published Sep 30, 2026

CVE-2026-103226Artifex Ghostscript Pdfwrite gdevpsfx.c type1_callsubr stack-based overflow

Updated under an hour ago ()

Does this affect you?

It affects Artifex Ghostscript. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A vulnerability was identified in Artifex Ghostscript up to 10.07.0. Affected is the function type1_callsubr of the file devices/vector/gdevpsfx.c of the component Pdfwrite. The manipulation leads to stack-based buffer overflow. Remote exploitation of the attack is possible. The exploit is publicly available and might be used. Upgrading to version 10.08.0 is able to address this issue. It is suggested to upgrade the affected component. A solution was implemented: "I've chosen to fix this slightly differently by using the defined macro in the font parsing loop rather than in the callsubr function, because this better matches the pattern of 'normal' usage."

CVSS
6.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L/E:P/RL:O/RC:C
Weakness (CWE)
CWE-121, CWE-119
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
VulDB
NVD analysis
Awaiting Analysis
Record last updated
Oct 15, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Artifex Ghostscript
artifex:ghostscript
10.07; 10.08.0 not affected
CNA record

References

  • vdb-entry, technical-description
  • signature, permissions-required
  • third-party-advisory
  • third-party-advisory
  • issue-tracking
  • issue-tracking
  • exploit
  • patch
  • product

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.